Boston Trust Walden Corp Lowers Holdings in Intuitive Surgical, Inc. $ISRG

Boston Trust Walden Corp lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,251 shares of the medical equipment provider’s stock after selling 61 shares during the period. Boston Trust Walden Corp’s holdings in Intuitive Surgical were worth $7,744,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of ISRG. Nuveen LLC purchased a new stake in Intuitive Surgical during the first quarter worth $1,715,899,000. Goldman Sachs Group Inc. raised its stake in shares of Intuitive Surgical by 26.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock worth $1,396,496,000 after acquiring an additional 584,375 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Intuitive Surgical by 20.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock worth $1,680,922,000 after acquiring an additional 566,979 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Intuitive Surgical by 15.0% during the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after acquiring an additional 457,080 shares in the last quarter. Finally, Vanguard Group Inc. raised its stake in shares of Intuitive Surgical by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after acquiring an additional 453,335 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $435.61 on Thursday. The firm has a market capitalization of $156.16 billion, a PE ratio of 60.75, a price-to-earnings-growth ratio of 4.58 and a beta of 1.61. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The company’s fifty day moving average price is $456.15 and its 200-day moving average price is $496.60.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same period in the previous year, the company earned $1.78 earnings per share. The business’s quarterly revenue was up 21.4% compared to the same quarter last year. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director directly owned 739 shares in the company, valued at approximately $325,669.91. The trade was a 31.19% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 45,224 shares of company stock worth $21,716,492. Company insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on ISRG. BTIG Research cut their price target on shares of Intuitive Surgical from $571.00 to $529.00 and set a “buy” rating on the stock in a report on Monday. The Goldman Sachs Group cut their price target on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a report on Wednesday, October 1st. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. Piper Sandler reaffirmed an “overweight” rating and issued a $595.00 price target (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Royal Bank Of Canada reiterated an “outperform” rating and issued a $615.00 target price on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $582.14.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.